Click Here to return To Results

 

Effect of Dextromethorphan-Quinidine on Agitation in Patients with Alzheimer Disease Dementia JAMA 314:1242-1254, Cummings, J.L.,et al, 2015 See this aricle in Pubmed Article Abstract In this preliminary 10-week phase 2 randomized clinical trial of patients with probable Alzheimer disease, combination dextromethorphan-quinidine demonstrated clinically relevant efficacy for agitation and was generally well tolerated

Related Tags

(click to filter results - removes previous filter) agitation Alzheimer's disease Alzheimer's disease,behavioral symptoms dextromethorphan quinidine treatment of neurologic disorder

Click Here to return To Results